Iclepertin
Iclepertin is a pharmaceutical drug with 7 clinical trials. Historical success rate of 85.7%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
0
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
85.7%
6 of 7 finished
14.3%
1 ended early
0
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study in Healthy Women to Test Whether BI 425809 Influences the Amount of a Contraceptive in the Blood
A Study to Test How Iclepertin is Taken up in the Blood of People With and Without Liver Problems
A Study to Test Long-term Safety of Iclepertin in People With Schizophrenia Who Took Part in a Previous CONNEX Study
CONNEX-3: A Study to Test Whether Iclepertin Improves Learning and Memory in People With Schizophrenia
Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-2)
Clinical Trials (7)
A Study in Healthy Women to Test Whether BI 425809 Influences the Amount of a Contraceptive in the Blood
A Study to Test How Iclepertin is Taken up in the Blood of People With and Without Liver Problems
A Study to Test Long-term Safety of Iclepertin in People With Schizophrenia Who Took Part in a Previous CONNEX Study
CONNEX-3: A Study to Test Whether Iclepertin Improves Learning and Memory in People With Schizophrenia
Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-2)
Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-1)
A Study in Healthy People to Test Whether Iclepertin Has an Effect on Cardiac Safety
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7